Lori Berk
Impact in
- Oncology top 10%
- Vascular Tumors and Angiosarcomas
-
- PI3K/AKT/mTOR signaling in cancer
- Epigenetics and DNA Methylation
- DNA Repair Mechanisms
Papers in
-
- PI3K/AKT/mTOR signaling in cancer 9
- CRISPR and Genetic Engineering 2
-
- Multiple Myeloma Research and Treatments 7
- Chronic Myeloid Leukemia Treatments 2
- Co-authors
- Victor M. Rivera (16 shared papers)Tim Clackson (9 shared papers)Teresa Druck (3 shared papers)Kay Huebner (3 shared papers)Frank G. Haluska (5 shared papers)John W. Loewy (3 shared papers)Koshi Mimori (2 shared papers)Carlo M. Croce (2 shared papers)
- Journals
- Cold Spring Harbor Protocols (3 papers)Journal of Clinical Oncology (2 papers)Cancer Chemotherapy and Pharmacology (2 papers)Annals of Oncology (2 papers)Proceedings of the National Academy of Sciences (2 papers)
- Partner nations
- United StatesSwitzerlandItaly
In The Last Decade
Lori Berk
20 papers receiving 770 citations
Peers
Comparison fields: 5 of 63
- Oncology 240
- Molecular Biology 535
- Genetics 199
- Hematology 79
- Pulmonary and Respiratory Medicine 224
Countries citing papers authored by Lori Berk
This map shows the geographic impact of Lori Berk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lori Berk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lori Berk more than expected).
Fields of papers citing papers by Lori Berk
This network shows the impact of papers produced by Lori Berk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lori Berk. The network helps show where Lori Berk may publish in the future.
Co-authors
The 25 scholars most cited alongside Lori Berk, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 195 | |
| 2 | 1999 | 106 | |
| 3 | 2011 | 87 | |
| 4 | 2009 | 71 | |
| 5 | 2001 | 58 | |
| 6 | 2009 | 47 | |
| 7 | 2010 | 36 | |
| 8 | 2012 | 30 | |
| 9 | FHITness and cancer. | 1998 | 29 |
| 10 | 2009 | 26 | |
| 11 | 2005 | 21 | |
| 12 | 2011 | 15 | |
| 13 | 2012 | 14 | |
| 14 | 2005 | 14 | |
| 15 | 2012 | 14 | |
| 16 | 2008 | 7 | |
| 17 | 2012 | 6 | |
| 18 | 2012 | 5 | |
| 19 | 2004 | 3 | |
| 20 | 2004 | 1 |
About Lori Berk
Lori Berk is a scholar working on Molecular Biology, Hematology, Genetics, Oncology and Genetics, having authored 20 papers that have together received 785 indexed citations. Recurring topics across this work include PI3K/AKT/mTOR signaling in cancer (9 papers), Multiple Myeloma Research and Treatments (7 papers), Virus-based gene therapy research (3 papers), Genetics and Neurodevelopmental Disorders (3 papers), Cancer Treatment and Pharmacology (2 papers), CRISPR and Genetic Engineering (2 papers), Fungal Plant Pathogen Control (2 papers) and Chronic Myeloid Leukemia Treatments (2 papers). The work is most often cited by research in Oncology (240 citations), Molecular Biology (535 citations), Genetics (199 citations), Hematology (79 citations) and Pulmonary and Respiratory Medicine (224 citations). Lori Berk has collaborated with scholars based in United States, Switzerland and Italy. Frequent co-authors include Victor M. Rivera, Tim Clackson, Teresa Druck, Kay Huebner, Frank G. Haluska, John W. Loewy, Koshi Mimori, Carlo M. Croce, Hansjüerg Alder and Anthony W. Tolcher. Their work appears in journals such as Cold Spring Harbor Protocols, Journal of Clinical Oncology, Cancer Chemotherapy and Pharmacology, Annals of Oncology and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.